新型神经疗法原则：AAN立场声明。

IF 8.5 1区医学 Q1 CLINICAL NEUROLOGY

Neurology Pub Date : 2025-06-25 DOI:10.1212/wnl.0000000000213850

Larry B Goldstein,Jonathan R Crowe,Anindita Deb,Justin T Jordan,Jonathan D Santoro,James J Sejvar,Madeline Turbes,Robert E Shapiro

{"title":"新型神经疗法原则：AAN立场声明。","authors":"Larry B Goldstein,Jonathan R Crowe,Anindita Deb,Justin T Jordan,Jonathan D Santoro,James J Sejvar,Madeline Turbes,Robert E Shapiro","doi":"10.1212/wnl.0000000000213850","DOIUrl":null,"url":null,"abstract":"This statement provides general principles of the American Academy of Neurology's (AAN) approach when invited to provide guidance to policymakers on a variety of types of therapies that may have neurologic treatment benefits, but for which available evidence is limited or for which there is no US Food and Drug Administration-approved indication. In these instances, the AAN recommends an approach in which the patient and neurologist carefully review all available evidence and discuss the potential risks and benefits of the therapy, including when patients are contemplating asserting their right to try.","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"55 1","pages":"e213850"},"PeriodicalIF":8.5000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Principles for Novel Neurologic Therapeutics: An AAN Position Statement.\",\"authors\":\"Larry B Goldstein,Jonathan R Crowe,Anindita Deb,Justin T Jordan,Jonathan D Santoro,James J Sejvar,Madeline Turbes,Robert E Shapiro\",\"doi\":\"10.1212/wnl.0000000000213850\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This statement provides general principles of the American Academy of Neurology's (AAN) approach when invited to provide guidance to policymakers on a variety of types of therapies that may have neurologic treatment benefits, but for which available evidence is limited or for which there is no US Food and Drug Administration-approved indication. In these instances, the AAN recommends an approach in which the patient and neurologist carefully review all available evidence and discuss the potential risks and benefits of the therapy, including when patients are contemplating asserting their right to try.\",\"PeriodicalId\":19256,\"journal\":{\"name\":\"Neurology\",\"volume\":\"55 1\",\"pages\":\"e213850\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2025-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1212/wnl.0000000000213850\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000213850","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

本声明提供了美国神经病学学会（AAN）方法的一般原则，该方法受邀为决策者提供关于可能具有神经学治疗益处的各种类型的治疗方法的指导，但现有证据有限或没有美国食品和药物管理局批准的适应症。在这些情况下，AAN建议患者和神经科医生仔细审查所有可用的证据，并讨论治疗的潜在风险和益处，包括当患者考虑维护他们尝试的权利时。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Principles for Novel Neurologic Therapeutics: An AAN Position Statement.

This statement provides general principles of the American Academy of Neurology's (AAN) approach when invited to provide guidance to policymakers on a variety of types of therapies that may have neurologic treatment benefits, but for which available evidence is limited or for which there is no US Food and Drug Administration-approved indication. In these instances, the AAN recommends an approach in which the patient and neurologist carefully review all available evidence and discuss the potential risks and benefits of the therapy, including when patients are contemplating asserting their right to try.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Neurology 医学-临床神经学

CiteScore

12.20

自引率

4.00%

发文量

1973

审稿时长

2-3 weeks

期刊介绍： Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology. As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content. Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.